Outcomes in patients with acute and stable coronary syndromes; insights from the prospective NOBORI-2 study

Mamas Mamas, Farzin Fath-Ordoubadi, Erik Spaepen, Magdi El-Omar, Douglas G. Fraser, Muhammad A. Khan, Ludwig Neyses, Gian B. Danzi, Ariel Roguin, Dragica Paunovic, Mamas A. Mamas

    Research output: Contribution to journalArticlepeer-review

    Abstract

    Background: Contemporary data remains limited regarding mortality and major adverse cardiac events (MACE) outcomes in patients undergoing PCI for different manifestations of coronary artery disease. Objectives: We evaluated mortality and MACE outcomes in patients treated with PCI for STEMI (ST-elevation myocardial infarction), NSTEMI (non ST-elevation myocardial infarction) and stable angina through analysis of data derived from the Nobori-2 study. Methods: Clinical endpoints were cardiac mortality and MACE (a composite of cardiac death, myocardial infarction and target vessel revascularization). Results: 1909 patients who underwent PCI were studied; 1332 with stable angina, 248 with STEMI and 329 with NSTEMI. Age-adjusted Charlson co-morbidity index was greatest in the NSTEMI cohort (3.78±1.91) and lowest in the stable angina cohort (3.00±1.69); P
    Original languageEnglish
    Article numbere88577
    JournalPLoS ONE
    Volume9
    Issue number2
    DOIs
    Publication statusPublished - 14 Feb 2014

    Fingerprint

    Dive into the research topics of 'Outcomes in patients with acute and stable coronary syndromes; insights from the prospective NOBORI-2 study'. Together they form a unique fingerprint.

    Cite this